Innovative In Vitro Chemo-Hormonal Drug Therapy for Refractory Thyroid Carcinomas

Tae-Yon SUNG; Sung-Ho CHOI; Jung-Min LEE; Jong-Ju JEONG; Sang-Wook KANG; Woong-Youn CHUNG.
Journal of Korean Medical Science ; : 729-735, 2012.
Artículo en Inglés | WPRIM | ID: wpr-7840

Documentos relacionados

  1. Innovative in vitro chemo-hormonal drug therapy for refractory thyroid carcinomas.
  2. Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care.
  3. Interactions between injectable anticancer drugs and polyvinyl chloride bags: Evaluation of the adsorption phenomenon after reconstitution.
  4. Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market.
  5. Electrochemical Recycling of Adenosine Triphosphate in Biocatalytic Reaction Cascades.
  6. Synthesis and Characterization of SiO<sub>2</sub>/nGO/Fe<sub>3</sub>O<sub>4</sub>/SeQDs Nanoparticles as Potential Nanocarriers in Drug Delivery Systems.
  7. Interaction between environmental pollutants and cancer drug efficacy: Bisphenol A, Bisphenol A diglycidyl ether and Perfluorooctanoic acid reduce vincristine cytotoxicity in acute lymphoblastic leukemia cells.
  8. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
  9. Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.
  10. Biotechnological advancements in Catharanthus roseus (L.) G. Don.